Oral vinorelbine (NVBO) in combination with trastuzumab (HER) in metastatic breast cancer (MBC): Data on efficacy and safety when administered in first- or second-line treatment.

被引：2
|
作者：
Illarramendi, J. J.
Blancas, I.
Bueso, P.
Carabantes, F.
Polo Marques, E.
Ciruelos Gil, E.
Corral, M.
Perez, F. J.
机构：
[1] Hosp Navarra, Pamplona, Spain
[2] Hosp Univ Clin San Cecilio, Granada, Spain
[3] Hosp Barbastro, Barbastro, Spain
[4] Hosp Univ Carlos Haya, Malaga, Spain
[5] Hosp Ernest Lluch, Calatayud, Spain
[6] Hosp 12 Octubre, E-28041 Madrid, Spain
[7] Hosp Alcaniz, Alcaniz, Spain
[8] Inst Catala Oncol, Clin Res Unit, Lhospitalet De Llobregat, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e11508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11508
引用
收藏
页数：1
相关论文
共 50 条
  • [41] All-oral vinorelbine (NVBo) and capecitabine (X) combination for chemotherapy-naive HER2-negative metastatic breast cancer (MBC) patients: efficacy and safety in an international phase II study
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Palumbo, R.
    Llombart, A.
    Villanova, G.
    Conte, P. F.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 173 - 173
  • [42] SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE
    Del Signore, E.
    Quadrini, S.
    De Sanctis, R.
    Stumbo, L.
    Gori, B.
    Recine, F.
    Adua, D.
    Basile, M. L.
    Tedeschi, M.
    Lo Russo, V
    Bucco, R.
    Longo, F.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [43] Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer
    Sugiyama, K.
    Ishikawa, A.
    Watanabe, T.
    [J]. IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 2009, : 119 - 122
  • [44] Effectiveness and safety of inetetamab plus pyrotinib plus vinorelbine in ≥second-line treatment of HER2-positive metastatic breast cancer
    Wu, Fan
    Chen, Mulan
    Huang, Weiwei
    Wang, Lili
    Li, Nani
    Wu, Xiufeng
    Chen, Xinhua
    Hong, Yi
    Lin, Lin
    Chen, Kan
    Liu, Jian
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [45] Effectiveness and safety of vinorelbine plus inetetamab plus pyrotinib in ≥second-line treatment of HER2-positive metastatic breast cancer
    Fan, W.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S364 - S364
  • [46] Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer
    Chew, Helen Kent
    Schwartzberg, Lee
    Badarinath, Suprith
    Rubin, Peter
    Shumaker, Grace
    Daugherty, James
    DeSilvio, Michelle
    Mahoney, Janine
    [J]. SPRINGERPLUS, 2014, 3
  • [47] Trastuzumab and vinorelbine combination in the treatment of Her2 positive metastatic breast cancer.
    Bayo, J
    Mayordomo, JI
    Sanchez-Rovira, P
    Perez-Carrion, R
    Illaramendi, J
    Flores, EG
    Bueno, JMG
    Vazquez, MR
    Crespo, C
    Palomo, AG
    Huelva, HJRJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 67S - 67S
  • [48] Efficacy of pertuzumab in combination with trastuzumab and a taxane in first-line treatment for metastatic breast cancer (MBC): A multicenter, retrospective, observational study
    Gamucci, Teresa
    Mentuccia, Lucia
    Sperduti, Isabella
    Gelibter, Alain
    D'Onofrio, Loretta
    Cassano, Alessandra
    Iezzi, Laura
    Botticelli, Andrea
    Pizzuti, Laura
    Moscetti, Luca
    Barchiesi, Giacomo
    Scinto, Fedele
    Carbognin, Luisa
    Cursano, Maria Concetta
    Foglietta, Jennifer
    Rossi, Ernesto
    Barni, Sandro
    Graziano, Vincenzo
    Magnolfi, Emanuela
    Vici, Patrizia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] A multicenter study with Trastuzumab and Vinorelbine as first and 2nd line treatment in patients (pats) with Her2 positive Metastatic Breast Cancer (MBC).
    Bayo-Calero, JL
    Mayordomo-Cámara, JI
    Sánchez-Rovira, P
    Pérez-Carrión, R
    Illaramendi, JJ
    García-Bueno, JM
    Gonzalez-Flores, E
    Crespo, C
    Ramos-Vazquez, M
    García-Palomo, A
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S207 - S208
  • [50] Second-line treatment of HER2+metastatic breast cancer (MBC): Trastuzumab (T) beyond progression or lapatinib (L)? A retrospective database study
    Yerushalmi, Rinat
    Feldhamer, Ilan
    Greenberg-Dotan, Sari
    Bitterman, Haim
    Hammerman, Ariel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345